Pro-benefit-agent compounds having heterocyclic moieties that include a benefit agent fragment derived from benefit agents, such as perfume raw materials, that include an aldehyde moiety or a ketone moiety. The pro-benefit-agent compounds may be derived from modified amino acids. Related treatment compositions, premix compositions, precursor compounds, and methods of making and using such materials and compositions.

The present invention generally relates to a system and process for producing a biosurfactant, and more particularly to a system and process for producing a biosurfactant from at least one strain of Bacillus subtilis, and formulations which comprise the biosurfactant.

A glycophospholipid polymer is disclosed. The glycophospholipid polymer comprises a reaction product of one or more glycosaminoglycans and one or more phospholipids. Also disclosed is a glycophospholipid polymeric network comprising a reaction product of one or more glycosaminoglycans, one or more phospholipids and, one or more crosslinking agents.

A biomedical device having a coating on a surface thereof, where the coating includes a glycophospholipid polymer which is a reaction product of one or more glycosaminoglycans and one or more phospholipids.

A bio-lubricant composition includes a first component that includes a first triglyceride, which is part of a cooking oil; a second component that includes a first epoxidized triglyceride; a third component that includes a hydroxylated triglyceride; a fourth component that includes a first fatty acid ester moiety; a fifth component that includes a first epoxidized fatty acid ester; and a sixth component that includes a hydroxylated fatty acid ester. A mixture of the first to sixth components at room temperature have a viscosity between 40 and 200 centipoise, and the composition is substantially free of free fatty acids.

A bio-lubricant composition includes a first component that includes a first triglyceride, which is part of a cooking oil; a second component that includes a first epoxidized triglyceride; a third component that includes a hydroxylated triglyceride; a fourth component that includes a first fatty acid ester moiety; a fifth component that includes a first epoxidized fatty acid ester; and a sixth component that includes a hydroxylated fatty acid ester. A mixture of the first to sixth components at room temperature have a viscosity between 40 and 200 centipoise, and the composition is substantially free of free fatty acids.

An ancillary laundry composition comprising: hydrolysed protein, free perfume and 0 to 2 wt. % anionic and/or cationic surfactant.

A toilet odor prevention tablet and method for automatic flush activation is described, where the toilet odor prevention tablet includes one or more of a plurality of plant-based oils, glycerine, a solid carrier, and one or more of a plurality of essential oils. The method of use for automatic flush activation includes providing a toilet odor prevention tablet, including all natural ingredients, and depositing the toilet bowl odor prevention tablet directly into a toilet tank, where placement of the tablet results in a film that reduces an odor emitting capacity of human excrement and delivers a fresh layer of odor prevention with every flush of a toilet.

A toilet odor prevention tablet and method for automatic flush activation is described, where the toilet odor prevention tablet includes one or more of a plurality of plant-based oils, glycerine, a solid carrier, and one or more of a plurality of essential oils. The method of use for automatic flush activation includes providing a toilet odor prevention tablet, including all natural ingredients, and depositing the toilet bowl odor prevention tablet directly into a toilet tank, where placement of the tablet results in a film that reduces an odor emitting capacity of human excrement and delivers a fresh layer of odor prevention with every flush of a toilet.

A glycophospholipid polymer is disclosed. The glycophospholipid polymer comprises a reaction product of one or more glycosaminoglycans and one or more phospholipids. Also disclosed is a glycophospholipid polymeric network comprising a reaction product of one or more glycosaminoglycans, one or more phospholipids and, one or more crosslinking agents.